Will the New England Patriots beat the Green Bay Packers at home on November 8, 2026?
4 seats worked this question alone; the panel agreed within a few points, so no debate was run. Code ran every test and computed the number. How the desk works
Judged by Kalshi KXNFLGAME-26NOV08GBNE-NE settlement at 2026-11-09: Kalshi KXNFLGAME-26NOV08GBNE-NE: resolves YES if New England Patriots win
The dispute that matteredAll four analysts land within 0.01 of each other (0.57-0.58), so there is no real probability disagreement. The substantive tension is methodological: how much to shrink the market-implied NE probability (0.595, stable, stationary, high-autocorrelation) toward the generic home-favorite base rate (~0.56-0.58 from the HAC regression, p=0.023 but r2=0.055). Sports Analyst and Quant Researcher shrink minimally (anchoring near market price), while Causal Skeptic shrinks further, arguing several candidate causal variables (d6, d7, d8) are unidentified or untestable (n=0) and that the headline regression may reflect selection bias in which series was chosen. I resolved this by treating the market price as the dominant, well-behaved signal (ADF-stationary, tight CI, no fresh shock in the window) but applying a modest downward shrink (0.595 → 0.58) consistent with the low r2 of the only causal test available and the unresolved, unconfirmed GB-win-rate counter-signal the Sports Analyst raised but could not verify before the cutoff.
Synthesis
- A market-implied NE win-probability series (labeled d1/d5 across analysts) stable at 0.595-0.605 over the last six readings as of 2026-11-04, with mean ~0.574-0.58 over the full sample.
- The complementary GB-implied probability (~0.405-0.41) sums to ~1.00 with the NE series, confirming a de-vigged matched pair.
- The current point spread is -3 for NE (home team).
- An ADF test rejects a unit root in the probability series (p=0.0013), i.e., it is observed to be stationary over the sampled window.
- Two requested correlation/causal checks (on unidentified variables, possibly d6/d7) returned n=0 and could not be computed.
- A calibration-weighted log-odds pool of the four analysts' probabilities, producing the deterministic committee number of 0.58.
- A bootstrap 95% CI on the historical mean of the market probability series: [0.5708, 0.5776] (describes the series' past central tendency, not necessarily the current live line).
- An HAC-robust regression estimating home-field point advantage on an n=52 comparable sample (+7.35 pts, 95% CI [1.0, 13.7]).
- The market has reached a settled consensus with no fresh news shock as of the 2026-11-06 12:30 UTC cutoff (inferred from flat recent readings and high autocorrelation, not from any confirmed injury/lineup report).
- An unconfirmed signal suggesting GB's season win rate may exceed NE's season win rate (Sports Analyst) -- flagged but not verified with a specific dataset or test in this round.
- That the HAC regression's generic home-field advantage (+7.35 pts, p=0.023, r2=0.055) is a plausible but weak explanatory factor for the current spread, not a strong causal driver.
- NE wins at home with probability 0.58 (consensus), credible interval [0.52, 0.64], reflecting shrinkage from the latest market read (0.595) toward the generic home-favorite base rate given the low-r2 causal support and the unresolved GB counter-signal.
- If one transacted at the current market-implied price of 0.595 on the NE side, expected return per $1 notional is approximately -0.015 (fair-value 0.58 vs. price 0.595), i.e., roughly priced-in with a slight edge against the NE buyer at current levels.
- Whether the GB season win-rate advantage flagged by the Sports Analyst is real and material, since it was never independently tested or quantified.
- Whether any injury, weather, or lineup news between 2026-11-06 12:30 UTC and kickoff on 2026-11-08 will move the line meaningfully (outside this analysis window).
- Whether the unidentified variables (d6, d7, d8) that returned n=0 on correlation tests have any causal bearing on the outcome -- entirely unvetted.
- Whether the committee's calibration-weighted pooling adequately penalizes the fact that three of four analysts' core evidence (d1) is the same market series, i.e., whether 0.58 overstates the effective independent evidence behind the number.
| Quantitative Researcher | 0.30 | Only analyst to run an independently-specified test (HAC regression on point-spread home advantage, n=52) rather than purely reading the market-probability series; largest comparable sample (n=101) and best-documented uncertainty (tight bootstrap CI). Still shares the same core market series (d1) as everyone else, so weight is capped by lack of full independence. |
| Causal Skeptic | 0.27 | Adds real value by explicitly flagging that most 'evidence' (d6, d7, d8, s1 vs s4/s5) is non-replicating, unidentified, or empty (n=0), and discounts for selection bias in which regression was highlighted. This is the most epistemically independent contribution in the panel, even though it uses the same underlying market series (d5) for its anchor. Calibration (brier 0.262, acc 0.514) is mid-pack. |
| Sports Analyst | 0.23 | Highest domain relevance (1.0 sports) and correctly identifies the matched de-vigged NE/GB pair, but smallest sample (n=21) and worst Brier (0.259 vs similar range) limits confidence; also introduces an unconfirmed GB-win-rate signal without verifying it, which is noted but not resolved. |
| Market Positioning Analyst | 0.20 | Lowest calibration accuracy (0.529) and the ADF stationarity test and d1 read are largely redundant with what Quant Researcher and Causal Skeptic already use from the same market series; adds confirmation that the price is settled but no new causal information. |
- If the Kalshi (or equivalent) NE-win market-implied probability moves outside the [0.50, 0.70] band before kickoff on 2026-11-08, the 'settled consensus, no fresh shock' premise is falsified.
- If an official injury report or lineup change affecting a starting QB or multiple starters on either team is published before 2026-11-08 kickoff, the no-news-shock assumption underlying this estimate is falsified.
- If NE loses outright on 2026-11-08, the directional forecast (P>0.5 for NE) is falsified; track this against the final score.
- If a replication check on the home-field-advantage regression using a larger or different comparable sample yields r2 statistically indistinguishable from zero or a sign-reversed point estimate, the causal support cited by the Quant Researcher is falsified.
All four analysts' calibration Brier scores (0.259-0.272) are only marginally better than a coin-flip-equivalent reference for a binary near-50/50 event, and accuracy figures (51-54%) indicate the segment-level track record provides weak differentiation; the pooled 0.58 should be treated as having wide true uncertainty despite the narrow stated analyst range, because the apparent agreement largely reflects shared reliance on one market series rather than four independently validated models.
The seats
Sports Analyst58%
58% NFL home favorites priced near 57-60% implied probability historically convert at close to their priced rate; home-field edge alone is roughly 57%.
If d8 (mean win rate 0.628, n=43) is in fact Green Bay's season-long win rate and d7 (0.512) is New England's, the market's ~59.5% NE home-win price may be underweighting GB's superior underlying team quality and overweighting home-field advantage alone; a form-adjusted model could put true NE win probability several points below the market's 0.595, making this a case of the market under-correcting for team strength rather than a mispriced opportunity in NE's favor.
- 183 observations of a stable, high-autocorrelation (0.86) market probability for NE clustered tightly between 0.49 and 0.61, with the last six readings flat at 0.595 — indicating a settled market view with no fresh news shock as of the cutoff.
- Complementary GB probability (0.405-0.41) sums to ~1.00 with d1, confirming these are a matched de-vigged market pair and NE is the consistent favorite.
If, by kickoff (2026-11-08, ~13:00-20:30 ET window), the Kalshi NE win probability moves below 0.50 on confirmed injury news (e.g., a starting QB or multiple starters ruled out) or Patriots are confirmed to be without a key starter the market hasn't priced in, this probability estimate should be revised down toward the new market level; if the game resolves and NE loses, this specific 0.58 call is falsified as directionally wrong for that outcome, though not necessarily miscalibrated given the stated 42% chance of NO."]
- d1 series represents the Kalshi-implied win probability for the New England Patriots (home team) in this matchup, given mean ~0.575 and last readings of 0.595, and because the question is framed around a Kalshi NE-win contract.
- d2 series represents the complementary (Packers) win probability, since d1(0.595)+d2(0.405)=1.00 on the most recent date, implying a two-sided, de-vigged market.
- d3/d4 (n=8 each, high variance) are recent game-by-game scoring margins for NE and GB respectively; sample too small for a reliable team-strength estimate.
- d5/d6 (n=32, values 1-10) are plausible weekly injury-report counts (questionable/out) for the two teams; treated as a rough proxy for missing players, not identity or position-specific severity.
- d7/d8 (n=43, binary) are season-long win/loss indicators for NE (~0.51) and GB (~0.63) respectively, though the exact team assignment is not labeled in the data and is inferred from context.
- No new injury or lineup news is observed between the last data points (2026-11-03/11-04) and the as_of time (2026-11-06 12:30 UTC); kickoff is 2026-11-08.
debate skipped: panel unanimous within 0.01
Quantitative Researcher58%
Loading…
Market Positioning Analyst58%
Loading…
Causal Skeptic57%
Loading…
Claims and evidence
The debate
| Sports | Quanti | Market | Causal | |
|---|---|---|---|---|
| Sports | ||||
| Quantitative | ||||
| Market Posit | ||||
| Causal Skept |
New England is a stable, moderate home favorite against Green Bay per the Kalshi market (~59.5% implied), consistent with typical home-field-advantage pricing; absent any fresh injury news in the window observed, I assign a probability close to the market price, adjusted slightly down for an unconfirmed signal that Green Bay's season win rate may exceed New England's.
The most recent market-implied probability (d1) of a Patriots home win is 0.595, slightly above the generic home-team base rate (~0.56-0.58) found in the comparable sample; the one directly tested predictive signal (s4) showed no demonstrable edge beyond base rate, so my estimate is anchored to the market read-through with modest shrinkage toward the base rate rather than any independently validated quantitative edge.
The market has already converged to a price (~0.595-0.60 implied probability, -3 spread) that matches the generic base rate for a home favorite of this size; the series is stationary, low-volatility, and highly autocorrelated, indicating a settled consensus with little residual tradeable edge for a directional NE-win position at current prices.
The only genuinely informative series here is d5 (a near-term, low-variance, high-autocorrelation probability track, mean 0.574, last=0.595), which is almost certainly a market-implied win probability. Everything else in this dataset is either non-replicating (s1 vs s4/s5), too weak to be causal (r2=0.064), or unidentified (d6, d7, d8 have no documented causal link to the outcome and tiny/odd samples). I anchor near the market consensus but discount toward the generic home-favorite base rate because the 'signal' tests contradict each other and no test rules out selection bias in which variable (d2) was chosen for the headline regression.
debate skipped: panel unanimous within 0.01
debate skipped: panel unanimous within 0.01
debate skipped: panel unanimous within 0.01
debate skipped: panel unanimous within 0.01
Consensus: 0.58 probability NE beats GB at home on 2026-11-08, CI [0.52, 0.64]. Base rate for a home favorite at this spread size (~-3) is approximately 0.56-0.58 per the HAC regression (weak, r2=0.055); the current market-implied price (0.595, stable, stationary, no fresh shock through cutoff) sits modestly above that base rate, and I shrink only slightly back toward 0.58 given (a) no verified new information, and (b) an unconfirmed GB win-rate counter-signal that no analyst could substantiate with a specific test. Collapsed duplicated evidence: Sports Analyst's d1/d2, Quant Researcher's d1, Positioning Analyst's d1, and Causal Skeptic's d5 are the same underlying market-implied probability series read four times -- treated here as ONE independent line of evidence, not four. The only genuinely distinct, independently-run test in the panel is the Quant Researcher's HAC home-field-advantage regression (weak, r2=0.055) and the Positioning Analyst's ADF stationarity test (confirms the market series is settled, not a directional signal itself). Tradeability: NOT attractively tradeable at current prices. The fair-value estimate (0.58) is close to the market-implied price (0.595), yielding an expected edge of roughly -1.5 cents per $1 notional if buying NE at the current line -- within the noise band given the panel's own calibration error (Brier ~0.26). This is a crowded, efficient-market question (crowding=0.75, novelty=0.15): point spreads on marquee NFL games are heavily arbitraged, and the only 'edge' identified here is a weak, low-r2 generic home-field effect that the market has very plausibly already priced in. If forced to express a view, the only marginally defensible trade is a small, low-conviction long GB position only if GB-side price drifts below approximately 0.37-0.38 (i.e., NE implied above ~0.62-0.63) without any accompanying news justification, since that would imply the market has drifted further from the base-rate-anchored fair value than current observations support. Absent such a price move, I recommend no new position -- the evidence base is too thin and too duplicated to justify deploying capital against an efficiently-priced sports market.
Assumptions
- reviewd1 series represents the Kalshi-implied win probability for the New England Patriots (home team) in this matchup, given mean ~0.575 and last readings of 0.595, and because the question is framed around a Kalshi NE-win contract.
- reviewd2 series represents the complementary (Packers) win probability, since d1(0.595)+d2(0.405)=1.00 on the most recent date, implying a two-sided, de-vigged market.
- reviewd3/d4 (n=8 each, high variance) are recent game-by-game scoring margins for NE and GB respectively; sample too small for a reliable team-strength estimate.
- reviewd5/d6 (n=32, values 1-10) are plausible weekly injury-report counts (questionable/out) for the two teams; treated as a rough proxy for missing players, not identity or position-specific severity.
- reviewd7/d8 (n=43, binary) are season-long win/loss indicators for NE (~0.51) and GB (~0.63) respectively, though the exact team assignment is not labeled in the data and is inferred from context.
- reviewNo new injury or lineup news is observed between the last data points (2026-11-03/11-04) and the as_of time (2026-11-06 12:30 UTC); kickoff is 2026-11-08.
- reviewd1 series represents a market-implied probability (moneyline-derived) of a New England Patriots win, with d2 being the complementary/opposing-side implied probability (sum ≈1.0, consistent with s2's strong negative correlation of -0.92).
- reviewd3/d4/d5 binary series and d8 point-differential series reflect a historical sample of ~50 comparable games used to estimate home-field effects, not necessarily all-Patriots games.
- reviews3's is_home coefficient (+7.35 pts, HAC p=0.023) is a generic home-field effect estimated on the available sample, applicable (with uncertainty) to this specific matchup.
- reviewNo new information (injuries, weather, lineup changes) after the 2026-11-04/11-06 data cutoff is available to this analysis.
- reviewd1 is the Kalshi (or similar) market-implied probability series for NE to win NE-GB; d2 is the complementary/GB-side implied probability series; d1+d2≈1.00-1.01 reflecting vig
- reviewd6/d7/d8 are point-spread series (negative = NE favored) from sportsbook lines tracked over the weeks leading into the Nov 8 game, with d6's last value (-3 on game date 11/08) being the most current consensus spread
- reviewd4/d5 are either a different book's moneyline-implied probabilities or a less liquid/leveraged contract on the same outcome, explaining their wider range and higher volatility than d1/d2
- reviewNo injury, weather, or lineup news beyond what is embedded in the Nov 1-4 price/line data is available to me
- reviewd5 is a market-implied win-probability series for the Patriots in this game (unverified from handle alone — label could be something else entirely)
- reviewd1, d2, d4 are binary outcome/signal indicators from past games, not confirmed to be about the Patriots specifically
- reviewd6, d7 are some count-based metric (possibly injuries, weather alerts, or betting volume) with no documented definition or causal theory tying them to game outcome
- reviewd3 appears to be a point-differential series (min -33, max 32) but its direction/sign convention (home vs away) is not confirmed
- reviewd8 (n=3, spread-like values -3 to -7.5) is too sparse to support any inference and may just be the posted betting line, which is again circular with the outcome
Simulated trade
The portfolio manager proposed no paper trade. Two independent, compounding reasons to decline: (1) No instrument in the available catalog (HENRY_HUB, UNG, XLE, VLO, MPC, PSX, CORN, BTC, ETH, WTI) expresses a view on an NFL point-spread/moneyline outcome — there is no sports-betting line or correlated proxy asset in this book, so the trade cannot be implemented in the simulated universe regardless of conviction. (2) Even setting aside instrument availability, the synthesized edge is not attractive: fair value P=0.58 [0.52,0.64] vs. market-implied 0.595 gives E[r]≈-0.015, smaller than the panel's own calibration error (Brier≈0.26) and well within noise once transaction costs (typical sports-book vig ~400-500bps round-trip equivalent) are applied. Crowding is high (0.75) and the only distinct evidence (HAC home-field regression, r2=0.055) is weak and plausibly already priced in. Four of five analyst inputs collapse to one duplicated market-price read, leaving an evidence base too thin to justify capital against an efficiently-priced, heavily arbitraged NFL spread market.
Forecasts
| Seat | Stage | P | Base | Resolves | Outcome | Brier |
|---|---|---|---|---|---|---|
| Committee | final | 58% | — | 2026-11-09 | No | 0.334 |
| Sports Analyst | prior | 42% | 58% | 2026-11-09 | No | 0.176 |
| Sports Analyst | independent | 58% | 58% | 2026-11-09 | No | 0.336 |
| Sports Analyst | revised | 58% | 58% | 2026-11-09 | No | 0.336 |
| Quantitative Researcher | prior | 42% | 56% | 2026-11-09 | No | 0.176 |
| Quantitative Researcher | independent | 58% | 56% | 2026-11-09 | No | 0.336 |
| Quantitative Researcher | revised | 58% | 56% | 2026-11-09 | No | 0.336 |
| Market Positioning Analyst | prior | 42% | 60% | 2026-11-09 | No | 0.176 |
| Market Positioning Analyst | independent | 58% | 60% | 2026-11-09 | No | 0.336 |
| Market Positioning Analyst | revised | 58% | 60% | 2026-11-09 | No | 0.336 |
| Causal Skeptic | prior | 40% | 55% | 2026-11-09 | No | 0.160 |
| Causal Skeptic | independent | 57% | 55% | 2026-11-09 | No | 0.325 |
| Causal Skeptic | revised | 57% | 55% | 2026-11-09 | No | 0.325 |